CLIVE DIX

Chief Executive Officer, C4X Discovery

Clive joined C4X Discovery, a pioneering Drug Discovery company, in 2014 and has been CEO since 2016. He is also non-executive chairman of Touchlight Genetics Ltd and Centauri Ltd, and a non‑executive Board member of the Medicines Discovery Catapult. Clive has more than 30 years’ experience in life science research and over 20 years in senior pharmaceutical industry positions. His expertise includes an in-depth understanding of all facets of drug discovery and development, a broad knowledge of the science, therapeutic and commercial landscape and has comprehensive experience of the pharmaceutical business and finance community. Previously, Clive was co-founder and chief executive of Convergence Pharmaceuticals Ltd, acquired by Biogen in 2015, Co-founder and chief executive of PowderMed Ltd, acquired by Pfizer in 2006 and senior vice president, research and development and a Board member of PowderJect Pharmaceuticals plc, acquired by Chiron Vaccines in 2003. Clive began his career in industry at Ciba-Geigy and then GlaxoWellcome and has been chairman of the BioIndustry Association.

 LIVE ONLINE

16 November 2020

BOOK YOUR PLACE NOW